Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Progyny, Inc.

Progyny, Inc. (PGNY) Stock Overview

Explore Progyny, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PGNY●NASDAQ
HealthcareMedical - Healthcare Information Services
$25.89
$0.47(1.85%)
U.S. Market opens in 2h 53m

Progyny, Inc. (PGNY)

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio26.87
EPS (TTM)$1.38
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$29.23
3 Months$23.58
1 Year Target$22.38

PGNY Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Progyny, Inc. (NASDAQ: PGNY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Progyny, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PGNY on the NASDAQ shows an RSI of 28.57, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $22.38 for the NASDAQ listing.

Key metrics behind Progyny, Inc.'s NASDAQ-traded stock include a P/E ratio of 26.87 and a market capitalization of 2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PGNY on the NASDAQ.

Price Performance (NASDAQ: PGNY)

1-Day Change
1.85%
5-Day Change
1.29%
1-Month Change
-19.04%
3-Month Change
10.12%
6-Month Change
25.13%
Year-to-Date (YTD) Change
0.82%
1-Year Change
12.27%
3-Year Change
-32.96%
5-Year Change
-43.88%
All-Time (Max) Change
62.42%

Contact Information

https://www.progyny.com
212 888 3124
1359 Broadway, New York City, NY, 10018

Company Facts

8,560 Employees
IPO DateOct 25, 2019
CountryUS
Actively Trading

Frequently Asked Questions